Figure 1.
The schema of the study evaluating the effect of AKT inhibitor vevorisertib as a single agent and in combination with sorafenib in a DEN-induced cirrhotic rat model of HCC.
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.